Health Care
Commentary
Read the latest on the 340B Drug Pricing Program
Reforming 340B to Serve the Interests of Patients, Not Institutions
By Anthony M. DiGiorgio, DO, MHA and Wayne Winegarden, PhD Enacted by the US Congress in 1992 to help entities serving lower-income and uninsured patients stretch their resources, the 340B Drug Pricing Program mandated drug companies give large discounts to covered entities (CEs). Judging the program on its outcomes, not its intentions, ...
Health Care
NEW BRIEF: Washington Must End Physician Price Controls, Reform Medicare Payment System to Prevent Doctor Shortages
SACRAMENTO – A new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute finds that artificially low reimbursement rates used by Medicare to contain costs are threatening patient care, and reform is needed to prevent future doctor shortages. Click to download the ...
Commentary
Read about Biden's plan to extend health insurance to DACA
Biden’s Healthcare Amnesty Solves Nothing — and at a Staggering Cost
The Biden administration recently finalized a rule extending subsidized health coverage to approximately 100,000 people without health insurance who entered the United States illegally. These folks are part of the Deferred Action for Childhood Arrivals, or DACA, program — a group sometimes known as “dreamers.” The new rule effectively rewrites ...
Commentary
Fauci Has Only Himself to Blame for His COVID Legacy
“We have seen complete fabrications become some people’s accepted reality,” Dr. Anthony Fauci laments in his new memoir “On Call: A Doctor’s Journey in Public Service.” Surely the good doctor means to speak about his ideological foes, who have long decried the heavy-handed response to COVID-19 that Dr. Fauci symbolizes. But today, ...
Commentary
We’re Closer Than Ever To Beating Alzheimer’s. Price Controls Could Change That.
Earlier this month, the U.S. Food and Drug Administration approved donanemab, a novel treatment for Alzheimer’s disease that Eli Lilly will sell under the brand name Kisunla. The drug targets amyloid, a type of protein that builds up in the brains of people with the disease. It was shown to slow the ...
Commentary
U.S. Left Take Note: UK’s Healthcare an Unending Nightmare
Great Britain has new leadership. The Labour Party rode dissatisfaction with the Conservative Party, and in particular its stewardship of the country’s National Health Service, to victory in this month’s elections. Democrats in the United States may hope they can follow their left-wing brethren to victory this fall by campaigning ...
Commentary
Biden has given us worse healthcare
President Joe Biden proudly touted his record on healthcare during last month’s disastrous presidential debate. “The American public has greater healthcare coverage today than ever before,” he proclaimed. That’s debatable, to say the least. His administration’s policies have caused health insurance costs to surge. Biden began his presidency by increasing public subsidies for coverage through the exchanges. ...
Commentary
Read Biden's latest defense of price controls on insulin
In Debate Biden Lost on Substance, Style, and More
President Joe Biden’s clumsy, halting performance at the first presidential debate was nothing short of disastrous. But the substance of his remarks, especially on healthcare, is just as worrying. Take his defense of the Inflation Reduction Act’s price controls on insulin for Medicare Part D enrollees. As the president put it, “We brought ...
Commentary
The Medicare doomsday clock ticks closer to midnight
One day, our grandchildren may talk about Medicare the way we talk about Bernie Madoff. In May, Medicare’s trustees released their annual report on the program’s finances, and things are not looking good. The entitlement spent $12 billion more than it took in from taxes in 2023. Absent change, Medicare’s ...
Commentary
Read about Biden's healthcare promises on the campaign trail
Joe Biden’s False Promise To Young Voters
In the lead-up to last month’s presidential debate, pundits predicted that President Biden would lean into his standard defense of his former boss’s signature healthcare legislation in a bid to attract young voters, whose lack of enthusiasm for the president has the White House worried. It’s safe to say that Team Biden ...
Read the latest on the 340B Drug Pricing Program
Reforming 340B to Serve the Interests of Patients, Not Institutions
By Anthony M. DiGiorgio, DO, MHA and Wayne Winegarden, PhD Enacted by the US Congress in 1992 to help entities serving lower-income and uninsured patients stretch their resources, the 340B Drug Pricing Program mandated drug companies give large discounts to covered entities (CEs). Judging the program on its outcomes, not its intentions, ...
NEW BRIEF: Washington Must End Physician Price Controls, Reform Medicare Payment System to Prevent Doctor Shortages
SACRAMENTO – A new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute finds that artificially low reimbursement rates used by Medicare to contain costs are threatening patient care, and reform is needed to prevent future doctor shortages. Click to download the ...
Read about Biden's plan to extend health insurance to DACA
Biden’s Healthcare Amnesty Solves Nothing — and at a Staggering Cost
The Biden administration recently finalized a rule extending subsidized health coverage to approximately 100,000 people without health insurance who entered the United States illegally. These folks are part of the Deferred Action for Childhood Arrivals, or DACA, program — a group sometimes known as “dreamers.” The new rule effectively rewrites ...
Fauci Has Only Himself to Blame for His COVID Legacy
“We have seen complete fabrications become some people’s accepted reality,” Dr. Anthony Fauci laments in his new memoir “On Call: A Doctor’s Journey in Public Service.” Surely the good doctor means to speak about his ideological foes, who have long decried the heavy-handed response to COVID-19 that Dr. Fauci symbolizes. But today, ...
We’re Closer Than Ever To Beating Alzheimer’s. Price Controls Could Change That.
Earlier this month, the U.S. Food and Drug Administration approved donanemab, a novel treatment for Alzheimer’s disease that Eli Lilly will sell under the brand name Kisunla. The drug targets amyloid, a type of protein that builds up in the brains of people with the disease. It was shown to slow the ...
U.S. Left Take Note: UK’s Healthcare an Unending Nightmare
Great Britain has new leadership. The Labour Party rode dissatisfaction with the Conservative Party, and in particular its stewardship of the country’s National Health Service, to victory in this month’s elections. Democrats in the United States may hope they can follow their left-wing brethren to victory this fall by campaigning ...
Biden has given us worse healthcare
President Joe Biden proudly touted his record on healthcare during last month’s disastrous presidential debate. “The American public has greater healthcare coverage today than ever before,” he proclaimed. That’s debatable, to say the least. His administration’s policies have caused health insurance costs to surge. Biden began his presidency by increasing public subsidies for coverage through the exchanges. ...
Read Biden's latest defense of price controls on insulin
In Debate Biden Lost on Substance, Style, and More
President Joe Biden’s clumsy, halting performance at the first presidential debate was nothing short of disastrous. But the substance of his remarks, especially on healthcare, is just as worrying. Take his defense of the Inflation Reduction Act’s price controls on insulin for Medicare Part D enrollees. As the president put it, “We brought ...
The Medicare doomsday clock ticks closer to midnight
One day, our grandchildren may talk about Medicare the way we talk about Bernie Madoff. In May, Medicare’s trustees released their annual report on the program’s finances, and things are not looking good. The entitlement spent $12 billion more than it took in from taxes in 2023. Absent change, Medicare’s ...
Read about Biden's healthcare promises on the campaign trail
Joe Biden’s False Promise To Young Voters
In the lead-up to last month’s presidential debate, pundits predicted that President Biden would lean into his standard defense of his former boss’s signature healthcare legislation in a bid to attract young voters, whose lack of enthusiasm for the president has the White House worried. It’s safe to say that Team Biden ...
